Sangamo Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Sangamo Therapeutics stock have an average target of 5.17, with a low estimate of 2.00 and a high estimate of 10. The average target predicts an increase of 530.49% from the current stock price of 0.82.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$5.17	$5.00	$10
Change	+143.90%	+530.49%	+509.76%	+1119.5%

Analyst Ratings

The average analyst rating for Sangamo Therapeutics stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	2	3	3	3
Buy	0	1	1	1	1	1
Hold	3	1	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	3	5	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luca Issi RBC Capital	RBC Capital	Hold Reiterates $2	Hold	Reiterates	$2	+143.90%	Mar 18, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+1,119.51%	Jan 27, 2025
Nicole Germino Truist Securities	Truist Securities	Strong Buy Maintains $7 → $5	Strong Buy	Maintains	$7 → $5	+509.76%	Jan 23, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+1,119.51%	Jan 2, 2025
Maury Raycroft Jefferies	Jefferies	Strong Buy Maintains $7 → $3	Strong Buy	Maintains	$7 → $3	+265.85%	Dec 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

53.13M

from 57.80M

-8.08%

from 57.80M

Revenue Next Year

75.34M

from 53.13M

41.81%

from 53.13M

EPS This Year

-0.30

from -0.49

EPS Next Year

-0.26

from -0.30

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	118.19M	110.70M	111.30M	176.23M	57.80M	53.13M	75.34M	173.05M
Revenue Growth	15.39%	-6.34%	0.54%	58.34%	-67.20%	-8.08%	41.81%	129.70%
EPS	-0.90	-1.23	-1.25	-1.48	-0.49	-0.30	-0.26	-
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	110.3M	142.8M	344.5M
Avg	53.1M	75.3M	173.1M
Low	20.4M	24.4M	43.0M

Revenue Growth

Revenue Growth	2025	2026	2027
High	90.7%	168.8%	357.3%
Avg	-8.1%	41.8%	129.7%
Low	-64.7%	-54.0%	-42.9%

EPS Forecast

EPS	2025	2026
High	0.26	-0.13
Avg	-0.30	-0.26
Low	-0.59	-0.57

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.